Patents: a necessary evil?
Dave Elder explores US patent developments amid growing concerns that current approaches may delay generic drugs and biosimilars entering the market.
Source: europeanpharmaceuticalreview.com
Stay updated with breaking news from Process Behind New. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dave Elder explores US patent developments amid growing concerns that current approaches may delay generic drugs and biosimilars entering the market.